Caribou Biosciences (CRBU) - News Mentions

Sign up to add (CRBU) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Boston Scientific
Boston Scientific
BSX		 0 0%
Edwards Lifesciences
Edwards Lifesciences
EW		 0 100%
Intuitive Surgical
Intuitive Surgical
ISRG		 0 0%
Medtronic
Medtronic
MDT		 0 0%
Stryker
Stryker
SYK		 1 0%
Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit
January 2
Caribou Biosciences appoints Sri Ryali as CFO
January 2
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
January 1
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences
January 1
ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
December 31
CRBU Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
December 31
ROSEN, A TOP-RANKED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
December 30
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
December 30
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Caribou Biosciences, Inc. (CRBU) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
December 30
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences
December 30
Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?
December 30
ROSEN, A TRUSTED FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CRBU
December 28
CRBU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Caribou Biosciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
December 27
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBU
December 27
CRBU Investors with Losses in Excess of $100K Have Opportunity to Lead Caribou Biosciences, Inc. (NASDAQ: CRBU) Securities Fraud Lawsuit
December 26
Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights
December 26

Month over Month

Est. daily news mentions.

Dec 2024 0
Nov 2024 0
Oct 2024 0
Sep 2024 0
Aug 2024 0

How often is Caribou Biosciences mentioned in the news?

Caribou Biosciences was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Caribou Biosciences performing compared to its industry peers?

Caribou Biosciences overperforms all of its industry peers when it comes to News Mentions, having more News Mentions than any of its peers.

Has there been an increase or decrease in news mentions of Caribou Biosciences in the last month?

There has been no significant change in the number of news mentions for Caribou Biosciences' compared to the last month.

Why is it important to track news mentions for Caribou Biosciences?

By monitoring mentions in the news for Caribou Biosciences, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Caribou Biosciences, ultimately improving their investment strategies.

Sign up and get more insights on Caribou Biosciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact